Brief: Synact Pharma CFO Patrik Renblad Resigns
Feb 1 (Reuters) - SynAct Pharma AB SYNACT.ST :
* CFO PATRIK RENBLAD HAS RESIGNED AND WILL MOVE TO A NEW
ASSIGNMENT OUTSIDE COMPANY
* PATRIK RENBLAD WILL LEAVE SYNACT BY END OF JULY 2023 AT
LATEST
* SEARCH FOR NEW CFO HAS BEEN INITIATED
Source text for Eikon: ID:nMFN1kjJkB
Further company coverage: SYNACT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development